ArticleACG case reports journal2024

Post-Chimeric Antigen Receptor T-Cell Therapy Hepatitis B Virus Reactivation After 23 Months of Entecavir Prophylaxis.

Caleb J C McKinney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.